BRD4 and acute myeloid leukemia: Bone marrow specimens from patients with azacitidine-resistant AML or MDS showed a significant increase in RNA:m5C and NSUN1-/BRD4-associated active chromatin as compared to specimens from patients with sensitive AML or MDS[108].